1. Home
  2. GIFT vs SCLX Comparison

GIFT vs SCLX Comparison

Compare GIFT & SCLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GIFT
  • SCLX
  • Stock Information
  • Founded
  • GIFT 1999
  • SCLX 2011
  • Country
  • GIFT United States
  • SCLX United States
  • Employees
  • GIFT N/A
  • SCLX N/A
  • Industry
  • GIFT Catalog/Specialty Distribution
  • SCLX Biotechnology: Pharmaceutical Preparations
  • Sector
  • GIFT Consumer Discretionary
  • SCLX Health Care
  • Exchange
  • GIFT Nasdaq
  • SCLX Nasdaq
  • Market Cap
  • GIFT 40.4M
  • SCLX 34.3M
  • IPO Year
  • GIFT N/A
  • SCLX N/A
  • Fundamental
  • Price
  • GIFT $1.14
  • SCLX $6.65
  • Analyst Decision
  • GIFT Strong Buy
  • SCLX Strong Buy
  • Analyst Count
  • GIFT 1
  • SCLX 3
  • Target Price
  • GIFT $4.00
  • SCLX $367.50
  • AVG Volume (30 Days)
  • GIFT 61.6K
  • SCLX 85.9K
  • Earning Date
  • GIFT 08-15-2025
  • SCLX 08-12-2025
  • Dividend Yield
  • GIFT N/A
  • SCLX N/A
  • EPS Growth
  • GIFT N/A
  • SCLX N/A
  • EPS
  • GIFT N/A
  • SCLX N/A
  • Revenue
  • GIFT $89,689,155.00
  • SCLX $50,710,000.00
  • Revenue This Year
  • GIFT $12.22
  • SCLX $107.00
  • Revenue Next Year
  • GIFT $13.86
  • SCLX $82.52
  • P/E Ratio
  • GIFT N/A
  • SCLX N/A
  • Revenue Growth
  • GIFT 6.13
  • SCLX 7.79
  • 52 Week Low
  • GIFT $0.50
  • SCLX $3.60
  • 52 Week High
  • GIFT $4.22
  • SCLX $73.50
  • Technical
  • Relative Strength Index (RSI)
  • GIFT N/A
  • SCLX 56.81
  • Support Level
  • GIFT N/A
  • SCLX $6.20
  • Resistance Level
  • GIFT N/A
  • SCLX $6.64
  • Average True Range (ATR)
  • GIFT 0.00
  • SCLX 0.41
  • MACD
  • GIFT 0.00
  • SCLX 0.05
  • Stochastic Oscillator
  • GIFT 0.00
  • SCLX 67.19

About GIFT RDE Inc. Common Stock

Giftify Inc through its wholly-owned subsidiary, has been in the business of connecting digital consumers, businesses and communities with dining and merchant deal options throughout the United States. The company connects digital consumers, businesses, and communities offering dining and merchant deal options nationwide restaurants, and retailers to customers. The Company buys merchant gift cards from the general public and distributors at a discount and then resells them at a markup.

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

Share on Social Networks: